Biomarkers of Osimertinib Response in Patients With Refractory, EGFR-T790M–Positive Non–Small Cell Lung Cancer and CNS Metastases
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Biomarkers of Osimertinib Response in Patients With Refractory, EGFR-T790M-Positive Non-Small Cell Lung Cancer and Central Nervous System Metastases: The APOLLO Study
Clin. Cancer Res 2020 Aug 17;[EPub Ahead of Print], L Xing, Y Pan, Y Shi, Y Shu, J Feng, W Li, L Cao, L Wang, W Gu, Y Song, P Xing, Y Liu, W Gao, J Cui, N Hu, R Li, H Bao, Y Shao, J YuFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.